No causal effect of serum urate on bone-related outcomes among a population of postmenopausal women and elderly men of Chinese Han ethnicity—a Mendelian randomization study

Osteoporosis International

Volumn 27, Issue 3, 2016, Pages 1031-1039

  Xiong, A ^a   Yao, Q ^a   He, J ^b   Fu, W ^b   Yu, J ^a   Zhang, Z ^b  

^a NINGBO FIRST HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Bone mineral density; Causal effect; Genetic; Mendelian randomization; Uric acid

Indexed keywords

CALCIFEDIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; URATE TRANSPORTER; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BONE; BONE DENSITY; BONE TURNOVER; CALCIUM BLOOD LEVEL; CHINA; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; EXPOSURE VARIABLE; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; GERIATRICS; HAN CHINESE; HIP; HUMAN; HUMAN EXPERIMENT; LUMBAR SPINE; MALE; MENDELIAN RANDOMIZATION ANALYSIS; OBSERVATIONAL STUDY; OUTCOME VARIABLE; PARATHYROID HORMONE BLOOD LEVEL; PHENOTYPE; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; URIC ACID BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; FEMORAL NECK; GENETICS; LUMBAR VERTEBRA; MIDDLE AGED; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; BONE DENSITY; FEMALE; FEMUR NECK; GENE FREQUENCY; HIP JOINT; HUMANS; LUMBAR VERTEBRAE; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; URIC ACID;

EID: 84959094373     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-015-3341-5     Document Type: Article

References (40)

1. Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM, Luo SQ (2004) Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 314:197–207
2. Ha H, Kwak HB, Lee SW, Jin HM, Kim HM, Kim HH, Lee ZH (2004) Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res 301:119–127
3. Ostman B, Michaelsson K, Helmersson J, Byberg L, Gedeborg R, Melhus H, Basu S (2009) Oxidative stress and bone mineral density in elderly men: antioxidant activity of alpha-tocopherol. Free Radic Biol Med 47:668–673
4. Bruce N, Ames RC, Elizabeth SH, Paul HC (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78:6858–6862
5. Hershfield MS, Roberts LJ, Ganson NJ, Kelly SJ, Santisteban I, Scarlett E, Jaggers D, Sundy JS (2010) Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo. Proc Natl Acad Sci U S A 107:14351–14356
6. Nabipour I, Sambrook PN, Blyth FM et al (2011) Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. J Bone Miner Res 26:955–964
7. Ahn SH, Lee SH, Kim BJ et al (2013) Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women. Osteoporos Int 24:2961–2970
8. Makovey J, Macara M, Chen JS, Hayward CS, March L, Seibel MJ, Sambrook PN (2013) Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone 52:400–406
9. Ishii S, Miyao M, Mizuno Y, Tanaka-Ishikawa M, Akishita M, Ouchi Y (2014) Association between serum uric acid and lumbar spine bone mineral density in peri- and postmenopausal Japanese women. Osteoporos Int 25:1099–1105
10. Lane NE, Parimi N, Lui L-Y, Wise BL, Yao W, Lay Y-AE, Cawthon PM, Orwoll E (2014) Association of serum uric acid and incident nonspine fractures in elderly men: the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res 29:1701–1707
11. Lee YJ, Hong JY, Kim SC, Joo JK, Na YJ, Lee KS (2015) The association between oxidative stress and bone mineral density according to menopausal status of Korean women. Obstet Gynecol Sci 58:46–52
12. Kim BJ, Baek S, Ahn SH et al (2014) Higher serum uric acid as a protective factor against incident osteoporotic fractures in Korean men: a longitudinal study using the National Claim Registry. Osteoporos Int 25:1837–1844
13. Zhang D, Bobulescu IA, Maalouf NM et al (2015) Relationship between serum uric Acid and bone mineral density in the general population and in rats with experimental hyperuricemia. J Bone Miner Res 30:992–999
14. Mehta T, Buzkova P, Sarnak MJ, Chonchol M, Cauley JA, Wallace E, Fink HA, Robbins J, Jalal D (2015) Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study. Metabolism 64:438–446
15. Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JA (2012) Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 21:223–242
16. Kottgen A, Albrecht E, Teumer A et al (2013) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 45:145–154
17. Sulem P, Gudbjartsson DF, Walters GB et al (2011) Identification of low-frequency variants associated with gout and serum uric acid levels. Nat Genet 43:1127–1130
18. Yang B, Mo Z, Wu C et al (2014) A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med Genomics 7:10
19. Pfister R, Barnes D, Luben R, Forouhi NG, Bochud M, Khaw KT, Wareham NJ, Langenberg C (2011) No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach. Diabetologia 54:2561–2569
20. Hughes K, Flynn T, de Zoysa J, Dalbeth N, Merriman TR (2014) Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function. Kidney Int 85:344–351
21. Rasheed H, Hughes K, Flynn TJ, Merriman TR (2014) Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels. Circ Cardiovasc Genet 7:830–837
22. Simon KC, Eberly S, Gao X et al (2014) Mendelian randomization of serum urate and Parkinson disease progression. Ann Neurol 76:862–868
23. Lu HK, Zhang Z, Ke YH, He JW, Fu WZ, Zhang CQ, Zhang ZL (2012) High prevalence of vitamin D insufficiency in China: relationship with the levels of parathyroid hormone and markers of bone turnover. PLoS One 7:e47264
24. Zhang H, He JW, Gao G et al (2010) Polymorphisms in the HOXD4 gene are not associated with peak bone mineral density in Chinese nuclear families. Acta Pharmacol Sin 31:977–983
25. Kolz M, Johnson T, Sanna S et al (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5, e1000504
26. Son CN, Bang SY, Cho SK, Sung YK, Kim TH, Bae SC, Jun JB (2014) The frequency of single nucleotide polymorphisms and their association with uric acid concentration based on data from genome-wide association studies in the Korean population. Rheumatol Int 34:777–783
27. Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575
28. Glickman ME, Rao SR, Schultz MR (2014) False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol 67:850–857
29. Davies NM, von Hinke Kessler Scholder S, Farbmacher H, Burgess S, Windmeijer F, Smith GD (2015) The many weak instruments problem and Mendelian randomization. Stat Med 34:454–468
30. Ja H (1978) Specification tests in econometrics. Econometrica 46:1251–1271
31. Burgess S, Daniel RM, Butterworth AS, Thompson SG, E-IC (2015) Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol 44:484–495
32. Freeman G, Cowling BJ, Schooling CM (2013) Power and sample size calculations for Mendelian randomization studies using one genetic instrument. Int J Epidemiol 42:1157–1163
33. Dalbeth N, Topless R, Flynn T, Cadzow M, Bolland MJ, Merriman TR (2015) Mendelian randomisation analysis to examine for a causal effect of urate on bone mineral density. J Bone Miner Res 30:985–991
34. Sritara C, Ongphiphadhanakul B, Chailurkit L, Yamwong S, Ratanachaiwong W, Sritara P (2013) Serum uric acid levels in relation to bone-related phenotypes in men and women. J Clin Densitom 16:336–340
35. Bonora E, Targher G, Zenere MB et al (1996) Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20:975–980
36. McAdams DeMarco MA, Maynard JW, Baer AN, Gelber AC, Young JH, Alonso A, Coresh J (2012) Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the atherosclerosis risk in communities cohort study. Arthritis Rheum 64:121–129
37. Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T (1999) Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet 354:650
38. Hui JY, Choi JW, Mount DB, Zhu Y, Zhang Y, Choi HK (2012) The independent association between parathyroid hormone levels and hyperuricemia: a national population study. Arthritis Res Ther 14:R56
39. 3 in patients with gout. Metabolism 47:336–338
40. Chen W, Roncal-Jimenez C, Lanaspa M, Gerard S, Chonchol M, Johnson RJ, Jalal D (2014) Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metabolism 63:150–160